Drug Discovery and Development Analysis & Statistics, July 2014 (p35)

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: clinical trial, drug discovery, drug development, more »

1021-1060 of about 3 300 reports

Purchase Reports From Reputable Market Research Publishers

Nitric Oxide Synthase (NO synthase) Inhibitors -Pipeline Insights, 2014

Nitric Oxide Synthase (NO synthase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Nitric Oxide Synthase (NO synthase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Drug Discovery and Development
NMDA Receptor 2B Antagonists -Pipeline Insights, 2014

NMDA Receptor 2B Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“NMDA Receptor 2B Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
NMDA Receptor Agonists -Pipeline Insights, 2014

NMDA Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“NMDA Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
Non Selective COX Inhibitors -Pipeline Insights, 2014

Non Selective COX Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Non Selective COX Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
Nrf2 Pathway Activators -Pipeline Insights, 2014

Nrf2 Pathway Activators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Nrf2 Pathway Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
NS3 Protease Inhibitors -Pipeline Insights, 2014

NS3 Protease Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“NS3 Protease Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
NS3/4A Protease Inhibitors  -Pipeline Insights, 2014

NS3/4A Protease Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“NS3/4A Protease Inhibitors -Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
NS5B Polymerase Inhibitors -Pipeline Insights, 2014

NS5B Polymerase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“NS5B Polymerase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Orexin Receptor (Hypocretin Receptor) Antagonists -Pipeline Insights, 2014

Orexin Receptor (Hypocretin Receptor) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Orexin Receptor (Hypocretin Receptor) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Orexin Receptor Type 1 (Ox1R or OX1) Antagonists -Pipeline Insights, 2014

Orexin Receptor Type 1 (Ox1R or OX1) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Orexin Receptor Type 1 (Ox1R or OX1) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Orexin Receptor Type 2 (Ox2R or OX2) Antagonists -Pipeline Insights, 2014

Orexin Receptor Type 2 (Ox2R or OX2) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Orexin Receptor Type 2 (Ox2R or OX2) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Ornithine Decarboxylase (ODC) Inhibitors -Pipeline Insights, 2014

Ornithine Decarboxylase (ODC) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Ornithine Decarboxylase (ODC) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Orotate Phosphoribosyltransferase (OPRT) Inhibitors -Pipeline Insights, 2014

Orotate Phosphoribosyltransferase (OPRT) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Orotate Phosphoribosyltransferase (OPRT) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Oxytocin Receptor Antagonists -Pipeline Insights, 2014

Oxytocin Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Oxytocin Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Drug Discovery and Development
P2X Receptor Antagonists -Pipeline Insights, 2014

P2X Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“P2X Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
P2X7 Receptor Antagonists -Pipeline Insights, 2014

P2X7 Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“P2X7 Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
PBP1A Inhibitors -Pipeline Insights, 2014

PBP1A Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“PBP1A Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
PDE 1 Inhibitors -Pipeline Insights, 2014

PDE 1 Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“PDE 1 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
PDE 10 Inhibitors -Pipeline Insights, 2014

PDE 10 Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“PDE 10 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Drug Discovery and Development
PDE 2 Inhibitors -Pipeline Insights, 2014

PDE 2 Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“PDE 2 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
PDE 3 Inhibitors -Pipeline Insights, 2014

PDE 3 Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“PDE 3 Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Drug Discovery and Development
Peptidoglycan Inhibitors -Pipeline Insights, 2014

Peptidoglycan Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Peptidoglycan Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
Peripheral Decarboxylase Inhibitors -Pipeline Insights, 2014

Peripheral Decarboxylase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Peripheral Decarboxylase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists -Pipeline Insights, 2014

Peroxisome Proliferator-Activated Receptor (PPAR) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Peroxisome Proliferator-Activated Receptor (PPAR) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Phosphodiesterase (PDE) Inhibitors -Pipeline Insights, 2014

Phosphodiesterase (PDE) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Phosphodiesterase (PDE) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
Phosphoinositide 3-Kinase Alpha (PI3K Alpha) Inhibitors -Pipeline Insights, 2014

Phosphoinositide 3-Kinase Alpha (PI3K Alpha) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Phosphoinositide 3-Kinase Alpha (PI3K Alpha) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitors -Pipeline Insights, 2014

Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Drug Discovery and Development
Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitors -Pipeline Insights, 2014

Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Phosphoinositide 3-Kinase Delta (PI3K Delta) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Drug Discovery and Development
Phospholipase C Inhibitors -Pipeline Insights, 2014

Phospholipase C Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Phospholipase C Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Drug Discovery and Development
PI3K/AKT/mTOR Pathway Inhibitors -Pipeline Insights, 2014

PI3K/AKT/mTOR Pathway Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“PI3K/AKT/mTOR Pathway Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Drug Discovery and Development
About 600 reports

Download Unlimited Documents from Trusted Public Sources

Evotec - Company Report, September 2014

  • Evotec Ag (evt.f)
  • September 2014
    29 pages
  • Drug Discovery ...  

    Drug Discovery  

  • United States  

View report >

83 Companies

Read our Company Profiles

Pfizer Inc.

United States

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

Novartis Inc.

Switzerland

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.